Chennai: There is a huge potential and opportunity to use artificial intelligence in the public health system and deliver proper care to the target population, said Dr Soumya Swaminathan, chairperson, ...

Join MIMS now and pay nothing for the first 30 days Join GPonline now and get full access.

Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

At 43, Bengaluru-based Dr Jagdish Chaturvedi is an ENT surgeon and also a stand-up comic. A 2001 MBBS batch graduate, he has built a unique career balancing the operating theatre with the stand-up ...

A special 79-year-old man has received unparalleled access to Eli Lilly's obesity drug. Millions of Americans are eagerly awaiting access to retatrutide, a powerful new drug from the pharmaceutical ...

More than half of patients diagnosed with binge eating disorder and one third of patients with atypical anorexia nervosa reported having used GLP-1 receptor agonists, according to a recent study ...

Forward Deployed Engineers, or FDEs, have become one of the fastest-growing AI job roles worldwide. From OpenAI to Cognizant, ...

In an extremely odd case, a single 79-year-old patient was granted early access to Eli Lilly’s powerful, still-experimental obesity drug retatrutide through the Food and Drug Administration’s ...

BEIJING, June 29 (Reuters) - China added 20 Japanese entities on Monday to its export control list for dual-use items, preventing Chinese firms from selling to them without prior approval, citing ...

China has added 10 United States-based companies to its export control list and barred government procurement from nearly 50 US companies two weeks after the Pentagon blacklisted some of China’s ...

White House officials on Tuesday shot down a report speculating President Trump gained access to the retatrutide weight loss drug under the Food and Drug Administration’s (FDA) “compassionate use ...